XENIOS Platform
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering  lung and heart therapies on one single platform.

THE PERFECT MATCH FOR YOUR NEEDS
•the unique platform for three applications combining ICU (novalung: iLA activve system platform), cath lab (i-cor: i-cor system) and OR (medos: deltastream system)
•adapt the system to your needs
•increased safety through integrated emergency functions